Evidence map›Paper›PMID 20522842›Full record

ArticleThorax2010

Gender differences in COPD: are women more susceptible to smoking effects than men?

Inga-Cecilie Sørheim, Ane Johannessen, Amund Gulsvik, Per S Bakke, Edwin K Silverman, Dawn L DeMeo

Abstract read
In one paragraph

Article in Thorax, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis.International journal of chronic obstructive pulmonary disease · 2018
    Pooled it
  3. Trial
  4. Trial
  5. Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study.International journal of chronic obstructive pulmonary disease · 2017
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Spirometric Lung Function Among Smokers and Non-Smokers: A Cross-Sectional Study in University Students.International journal of environmental research and public health · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  20. The importance of mechanical forces in chronic respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Inga-Cecilie SørheimInstitute of Medicine, University of Bergen, Bergen, Norway.
Ane Johannessen
Amund Gulsvik
Per S Bakke
Edwin K Silverman
Dawn L DeMeo

Funding

Genetic Features of Gender Differences in COPDR01HL089438 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMEO, DAWN L · 2008 to 2011
$3.3M
NHLBI NIH HHS R01 HL089438
6 · The paper itself

Abstract

backgroundThe number of female smokers developing chronic obstructive pulmonary disease (COPD) is rapidly increasing, but whether or not there exists a differential susceptibility by gender remains controversial.

methodsHow smoking behaviour and subsequent lung function reduction differed by gender was examined in a study including 954 subjects with COPD and 955 subjects without COPD. The study focused on two subgroups: subjects with COPD <60 years of age (early-onset group, n=316) and subjects with COPD with <20 pack-years of smoking (low exposure group, n=241).

resultsIn the low exposure group, female subjects with COPD had lower forced expiratory volume in 1 s (FEV(1)) % predicted (48.7% vs 55.8%, p=0.001) and more severe disease (50.4% vs 35.6%, p=0.020, in GOLD (Global Initiative for Chronic Obstructive Lung Disease) stage 3 and 4) than male subjects with COPD. Females also had lower FEV(1)% predicted (50.6% vs 56.0%, p=0.006) and more severe COPD (41.7% vs 31.1% in GOLD stage 3 and 4, p=0.050) in the early-onset group. Using multivariate regression, female gender was associated with 5.7% lower FEV(1)% predicted in the low exposure group (p=0.012) and a similar trend was observed in the early-onset group (p=0.057). The number of pack-years was not significantly associated with lung function in female subjects with COPD in this study, and the dose-response relationship between smoking and lung function differed by gender at lower levels of smoking exposure. Interaction analysis suggested that the effect of smoking on lung function might be different by gender (p=0.027 in all subjects with COPD).

conclusionsFemale gender was associated with lung function reduction and more severe disease in subjects with COPD with early onset of disease or low smoking exposure. The findings may suggest a gender difference in susceptibility to the lung-damaging effects of cigarette smoking, but alternative explanations should be considered.

Indexed as

Sex FactorsAdultAgedAge FactorsAsthmaDisease SusceptibilityFemaleForced Expiratory VolumeHumansMaleMiddle AgedNorwayPulmonary Disease, Chronic ObstructiveRisk FactorsSmoking

Identifiers

PMID20522842
PMCPMC8191512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.